Does sorafenib sensitize head and neck squamous cell carcinoma cells to ionizing radiation?
Our data suggest that sorafenib may be used to overcome the radioresistance of HNSCC through the inhibition of DSB repair.
The serum HA level (>200 ng/ml) is a useful predictor of PLA in HCC patients undergoing LR. As PLA leads to poor prognosis, the surgical method for HCC patients with an elevated serum HA level should be carefully considered.